Jak Knowles

Jak Knowles, President & CEO, Affini-T Therapeutics, shares insights on capital challenges in biotech, importance of key partners, early IP, experienced investors, and Affini-T's innovative approach to solid tumors using cell therapy and synthetic biology. Essential for biotech entrepreneurs.